Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message| ()  

Do you like to follow smart money buying and selling trends? One group of smart money investors includes short sellers, who take positions that are profitable if a stock price falls.

We ran a screen on the biotech industry to find which stocks investors are selling short. We began by screening the biotech industry for stocks with high growth prospects, with 5-year projected EPS growth above 15%.

We then screened these names for those with bearish sentiment from short sellers, with significant increases in shares shorted month-over-month as a percent of share float. This indicates that short sellers are more bearish on these names than they were a month ago.

Interactive Chart: Press Play to compare changes in market cap over the last two years for the stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

Do you think these stocks will underperform like short sellers expect? Use this list as a starting point for your own analysis

1. Abiomed Inc. (ABMD): Engages in the research, development, and sale of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Market cap at $510.95M, most recent closing price at $12.88. Shares shorted have increased from 7.23M to 7.63M over the last month, an increase which represents about 1.15% of the company's float of 34.72M shares. Days to cover ratio at 8.96 days. Next 5-year EPS growth at 40%.

2. Align Technology Inc. (ALGN): Designs, manufactures, and markets the invisalign system for treating malocclusion or the misalignment of teeth. Market cap at $2.15B, most recent closing price at $26.36. Shares shorted have increased from 6.35M to 8.90M over the last month, an increase which represents about 4% of the company's float of 63.71M shares. Days to cover ratio at 5.46 days. Next 5-year EPS growth at 20%.

3. Bio-Reference Laboratories Inc. (BRLI): Provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, primarily in the greater New York metropolitan area. Market cap at $804.13M, most recent closing price at $29.03. Shares shorted have increased from 9.01M to 9.72M over the last month, an increase which represents about 2.9% of the company's float of 24.49M shares. Days to cover ratio at 28.49 days. Next 5-year EPS growth at 19%.

4. Edwards Lifesciences Corp. (EW): Edwards Lifesciences Corporation offers products and technologies designed to treat advanced cardiovascular disease worldwide. Market cap at $10.5B, most recent closing price at $91.02. Shares shorted have increased from 3.57M to 5.46M over the last month, an increase which represents about 1.65% of the company's float of 114.37M shares. Days to cover ratio at 4.61 days. Next 5-year EPS growth at 21%

5. Exact Sciences Corporation (EXAS): Focuses on developing a molecular diagnostic screening technology for the early detection and prevention of colorectal pre-cancer and cancer. Market cap at $635.15M, most recent closing price at $9.96. Shares shorted have increased from 5.81M to 6.65M over the last month, an increase which represents about 1.44% of the company's float of 58.27M shares. Days to cover ratio at 10.53 days. Next 5-year EPS growth at 18%

6. GenMark Diagnostics, Inc. (GNMK): Operates as a molecular diagnostics company primarily in the United States. Market cap at $308.4M, most recent closing price at $9.44. Shares shorted have increased from 542.38K to 853.56K over the last month, an increase which represents about 1.09% of the company's float of 28.55M shares. Days to cover ratio at 5.83 days. Next 5-year EPS growth at 30%

7. Herbalife Ltd. (HLF): A network marketing company that sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. Market cap at $4.75B, most recent closing price at $43.94. Shares shorted have increased from 16.98M to 20.72M over the last month, an increase which represents about 3.52% of the company's float of 106.13M shares. Days to cover ratio at 12.36 days. Next 5-year EPS growth at 16%.

8. Heartware International Inc. (HTWR): Develops and manufactures small implantable heart pumps or ventricular assist devices for the treatment of advanced heart failure. Market cap at $1.17B, most recent closing price at $81.05. Shares shorted have increased from 1.57M to 2.08M over the last month, an increase which represents about 4.09% of the company's float of 12.47M shares. Days to cover ratio at 10.48 days. Next 5-year EPS growth at 64%.

9. IPC The Hospitalist Company, Inc. (IPCM): Provides hospitalist services in the United States. Market cap at $642.85M, most recent closing price at $38.54. Shares shorted have increased from 2.01M to 2.18M over the last month, an increase which represents about 1.05% of the company's float of 16.20M shares. Days to cover ratio at 19.26 days. Next 5-year EPS growth at 17%.

*Short data sourced from Yahoo Finance, all other data sourced from Finviz.

Source: 9 High-Growth Healthcare Stocks With Bearish Stock Trends